Boehringer Ingelheim and Oxford BioTherapeutics Partnership Advances Second Oncology Drug Candidate into the Clinic Read more
Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years Read more
FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ (SB11), LUCENTIS Biosimilar (ranibizumab-nuna) Read more
Hikma and FAES Farma enter into exclusive licensing agreement for the commercialisation of Bilastine tablets in the US Read more
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS) Read more
Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference Read more
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics Read more